Your browser doesn't support javascript.
loading
Clinical Observation of Shenmai Injection in Treatment of Primary Sjogren Syndrome / 中国药房
China Pharmacy ; (12)2001.
Artículo en Chino | WPRIM | ID: wpr-533603
ABSTRACT

OBJECTIVE:

To observe the clinical effect of Shenmai injection for primary sjogren syndrome.

METHODS:

61 patients were randomized to receive anethole trithione (control group,n=29) or anethole trithione and Shenmai injection (treatment group,n=32) respectively with 15 days as a course of treatment.

RESULTS:

The total effective rate was 68.96% for control group and 90.63% for treatment group.There were 3 cases of abdominal discomfort ordiarrhea in control group,and no serious ADR was detected in treatment group.Significant difference was noted between two groups (P

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Chino Revista: China Pharmacy Año: 2001 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Chino Revista: China Pharmacy Año: 2001 Tipo del documento: Artículo